This article is available to subscribers. Subscribe now. Already have an account? Sign in
Pretomanid in the Treatment of Patients with Tuberculosis in the United States
Investigators report findings from the use of an all-oral regimen of bedaquiline, pretomanid, and linezolid in patients in the United States with multidrug-resistant or extensively drug-resistant tuberculosis.
Neela D. Goswami, M.D., M.P.H.
Centers for Disease Control and Prevention, Atlanta, GA
David Ashkin, M.D.
Connie A. Haley, M.D.
University of Florida, Gainesville, FL
for the BAM Project Team
Funding and Disclosures
Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.
A list of the BAM Project Team investigators is available in the Supplementary Appendix, available at NEJM.org.
Print Subscriber? Activate your online access.